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ABSTRACT 
SEXUAL DIFFERENTIATION OF THE RAT HYPOTHALAMUS: 
AN EV ALUA TJON OF SEXUAL BEHAVIOR AND HYPOTHALAMIC 
MORPHOLOGY FOLLOWING NEONATAL MANIPULATION 
Michael C. Stamper. M. S. 
Morehead State University, 1984 
Sexual differentiation of venebrate reproductive and behavioral patterns is largely 
effected by hormones produced by the gonads. In many higher vertebrates, an integral part of 
this process is the induction of permanent. irreversible sex differences in central nervous 
function in response to gonadal hormones secreted early in developmenL The period of time 
during which the animal"s central nervous system is susceptible to the differentiating effect of 
these gonadal hormones is of limited duration and is termed ·critical period'. The approximate 
time for critical period in the rat is the first week post-partum. It is believed that mammalian 
central nervous system development inherently follows a female pattern with critical period 
exposure to testicular hormones resulting in a repression of female traits (defeminization) and 
the induction of male traits (masculinization). In this study, neonate rats were subjected to a 
variety of treatments in order to further elucidate the effects of progesterone. clomiphene (a 
non-steroidal anti-estrogen) and flutamide (a non-steroidal anti-androgen), and to clarify the 
role of the androgen receptor in differentiation of the central nervous system. Animals were 
subjected to bilateral gonadectomy at 60 days of age, and two weeks later their ability to exhibit 
female sex behavior in response to hormonal priming was quantitated. Additionally, 
histological studies upon these animals' brains were performed in order to quantitate the 
iii 
volume of the Sexually Dimorphic Nucleus of the Preoptic Area. a sexually dimorphic nucleus 
the volume of which bas been shown to be steroidally mediated. 
Progesterone was not found to effect defeminization of sex behavior. Clomiphene acted 
as an extremely potent estrogen agooist. Flutamide significantly attenuated testosterone 
propionate-induced defeminization of sex behavior. possibly by blocking androgen receptor 
system mediation of the enzyme aromatase. Brain morphology data did not achieve statistical 
significance. 
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INTRODUCTION 
In many vertebrate species. an integral part of the reproductive process is the 
development of mnrted sex differences in the control of endocrine function and behaYior by the 
central nervous system (CNS). Reproductive events, such as recognition of a suitable sex 
partner, mating, and the production and rearing of young are dependent upon normal sex 
differentiation of the CNS ( I). Of extreme importance in the development of these sex . 
differences are gonadal steroids (2). 
Early endocrine research suggested that the type of sexual behavior displayed was 
dependent only upon the nature of the hormone administered. For example, it was believed that 
testicular hormones stimulated the expression of masculine behavior equally well in adult 
members of either sex, and that a similar situation existed in regard to the elicitation of 
feminine behavior witb ovarian hormones (3). It is now accepted that permanent sex differences 
in morphology and function are imposed upon the CNS in many animals during their early 
developmental history. Depending on tbe sex of tbe animal. these differences result in 
heterogenous display of hormonally-stimulated behavior in the adult, and are largely mediated 
by gonadal hormones present during the perinatal period 0.2.4.5). 
A general hypothesis has been formulated for the mechanism of CNS sexual 
differentiation which has much in common with tbe model for differentiation of the embryonic 
reproductive tract (6). CNS development inherently folluws a pattern appropriate for the 
homogametic sex. Io the heterogametic sex, hormones produced by the gonads results in 
differentiation awa:y from this pattern. Thus, in mammals the intrinsic pattern is female, with 
1 
2 
exposure lo testicular hormones. b_eing necessary for differentiation toward male patterns of 
gonadotrophin secretion, behavior and CNS morphology (7). In contrast, the homogametic sex in 
birds is the male. Thus, the intrinsic pattern is male, with exposure to ovarian hormones being 
necessary for differentiation toward the female CNS phenotype (8). 
In mammals, differentiation involves two processes: defeminization, which is the 
repression of feminine traits (i.e., cyclic gonadotrophin release, sexually receptiYe behavior in 
the presence of a male following estrogen-progesterone priming, etc.I: and masculinization. 
which is the superimposition of a male trait upon the original homogametic (female) pattern 
(i.e .. mounting of females. masculine pattern of brain morphology, etc.l. 
Critical Period 
The period of time during which an animal's CNS is susceptible to the differentiating 
effect of gonadal hormones is of limited duration and is termed 'critical period' (see Table I). 
Critical period bas been delineated with some degree of precision in four placental mammals 
(rat, guinea pig. sheep, and rhesus monkey) by examination of neuroendocrine and behavior 
patterns following hormone treatments given at different times during their development ( I). 
More approximate times for critical period are known for several other species (mouse, hamster. 
ferret, dog, and several species of birds) (I). Critical period for the rat is generally stated to be 
the first week post-partum, although this is a concept developed through the more obvious 
characteristics of reproductive function and behavior, and recent evidence suggests that it may 
be misleading to imply precise boundaries in lime for critical period ( 1.5). For example. in the 
rat, while defeminization of cyclic gonadotropbin release and female sex behavior seems to be 
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Table I. Time or Critical Period for Sexual Differentiation or the CNS in Several Species. Taken 
from MacLustey and Naftolin (I). 
Animal Gestation or Incubation Critical Period 
(!!m) (After Conception) 
Rat 20-22 18-27 days 
Mouse 19-20 Postoatat 
Hamster 16 Postoatal 
Guinea pig 63-70 30-37 days 
Ferret 42 Postoatal 
Dog 58-63 Prenatal • postoatal 
Sheep 14,-1,, -30-90 days 
Rhesus montey 146-180 -40-60 days 
Domestic chicken 22 Prehatching 
Zebra finch 12-14 Posthatching · 
sensitive to steroidal influence primarily during the first few days post-partum, male sex 
behavior is highly sensitive to androgen treatment before birth (91. Additionally, since critical 
period may be lengthened under experimental conditions by increasing the dosages or hormones 
administered. Feder (51 argues that the term 'maximal susceptability period' is a more accurate 
reflection of biological reality and should be used instead or critical period. 
The issue or critical period in the rat has been further clouded by research performed 
by Gladue and Clemens (ID) and McPherson and Mahesh (11). Gladue and Clemens report that 
long-term prenatal exposure to the anti-androgen rtutamide (days ID-22 post-conception) can 
attenuate the defeminization of sexual behavior in males. McPherson and Mahesh have shown 
that the female pattern or gonadolrophin release !i.e., a Luteinizing Hormone-Follicle 
Stimulating Hormone (LH-FSH) surge] may be induced by certain doses of progesterone in a male 
rat that bas been castrated at day 26 post-partum and subsequelltly estrogen primed. Current 
evidence SUIIB83ts that this female pattern of gonadotrophin release cannot be induced in the 
adult male rat, implying that the critical period defeminization of gonadotrophin release bas not 
yet been 'finalized' by day 26 post-partum. MacLusty and Naftolin SUBBest that while CNS 
function can be orl!llllized by a single exposure to gonadal steroids during critical period, 
differentiation is not always complete during this period, full dBYelopment being partially 
dependent upon subsequent hormonal exposure (I). 
Gonadal Hormones 
The primary hormonal product or the developing testis is testosterone. Injection or 
testm:terone essentiaUy duplicates the androgenization effects produced by the presence of 
testes, suggesting that testosterone ls the testicular factor responsible for sexual 
differentiation of the mammalian CNS (6,12,13,14). However, sexual differentiation cannot be 
viewed as a simple matter or testosterone being present in the mate and absent in the female. In 
the rat, systematic radioimmunoassay bas indicated that androgens circulate in the femaJe as 
well as the mil.le during criticaJ period, though the relative amounts or androgen are 
controversial (I). Some earlier reports have indicated consistently higher testosterone values 
in the male during critical period (15.16), while others have reported that consistent sex 
differences in serum testosterone during critical period do not exist (17,18). More recent 
(1984) wort by Rhoda, Corbier and Rom (19), using specific radiolmmunoassays, strongly 
suggests that there is a dramatic and transient testosterone increase in both serum and 
hypothaJamus during the first two hours post-partum in the male that is not present in the 
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female. This surge does not occur in a gonadectomized male. indicating that this surge is tinted 
to the presence of testes. This data is particularly pertinent in Tiew of the theory that brief 
exposure to high levels of testosterone· may sensitize the developing male CNS to subsequent 
lower levels of testosterone (20). Thus, after the testosterone surge in the male during the first 
few hours post-partum. similar testosterone concentrations in male and female could produce 
entirely different effects (20). 
It bas also been suggested that there may be gonadal hormones that serve to protect the 
female's hypothalamus from the effects or testosterone. It has been shown that, in the rat, the 
presence or ovaries tends to inhibit the defeminizing effects of critical period treatment of the 
animal with androgen (2n This, along with evidence that progesterone can exhibit some 
anti-androgenic effects bas led some researchers to suggest that progesterone may be of 
importance as a protective mechanism for the female"s hypothalamus in some species 
U.2.4.9.22!. 
Mechanisms or Steroid Action 
Steroid hormones are transported in the plasma bound to a. variety or proteins in. an 
inactive form (23). However. small a.mounts of free, unbound steroid may enter a cell through 
passive dirrusion and bind to a receptor characterized by a high degree of affinity and 
specificity for the ligand (24). While it bas long been believed that this receptor is a 
cytoplasmicly located protein which is translocated to the nucleus in a different form after 
steroid binding (25.26). recent evidence suggests that both forms of the steroid receptor may 
actually be localized in the nuclear compartment, with binding or steroid resulting in a change 
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in receptor affinity for nuc:lear elements rather than a nuc:lear translocation of the receptor. 
What has been termed the 'cytoplasmic' receptor is proposed to be an extnu:tion artifact 
(27,28). This most recent evidence regarding the subject or translocation is incorporated. into 
Figure 3. 
Binding of hormone to receptor is followed by the hormone-receptor complex 
associating with chromatin (29) and subsequent mRNA synthesis and protein formation (30). 
Neural Gonadal Steroid Receptors in the Critical Period Brain 
In the neonatal rat. several areas within the hypothalamus. preoptic area. and amygdala 
hllYe been found to concentrate testosterone or its metabolites (31 ). Neural estrogen, androgen, 
and prOKestin receptors in the rat are present in very low quantities prior to birth and increase 
dramatically in the immediate postnatal period. Estrogen receptors increase first, starting just 
before birth and continuing through day five or six post partum (32,33). Progesterone receptors 
begin to increase shortly after birth and rise-in parallel with the estrogen receptor system (34). 
It should be noted that the progesterone receptor is not induc:ed by estrogen until after critical 
period, which has led McEwen, among others, to hypothesize that the estrogen receptor is not 
"hooked up to normal cell function during critical period,· since provision or estrogen to a cell 
which is estrogen receptor positive results in the production of progesterone receptor in the 
adult (35). Androgen receptors start to increase about one week post-partum (36). 
Autoradiographic and biochemical studies indicate that androgen and estrogen 
receptors can 1Jind within cell nuc:lei in the developing rat brain ( I). There have been no 
similar reports on whether the progesterone receptor is also functional in terms Ii[ nuclear 
,7 
binding. 
Androgen Metabolites and the Aromatization Hypothesis 
Figure I illustrates the various potential metabolic paths through which testosterone 
may be transformed and exert an influence upon a target tissue (37). The pathway that seems to 
b11 of primary importance is the conversion of testosterone to 170-estradiol via the enzyme 
aromatase. as illustrated in Figure 2. 
Critical period exposure to estrogen produces results extremely similar to those 
resulting.from exposure to testosterone. The postnatal injection of testosterone propionate or 
estrogen beozoate to the intact female (38,39,40,41) or the neonatally castrated male (42,43,44) 
suppresses feminine reproductive behavior in adulthood. The feminine pattern of cyclic 
gonadotrophin r11lease may b11 changed to the tonic pattern of the mal11 in lite fashion (7), 
suggesting that estrogen may be the terminal effector hormone for many aspects of brain 
differentiation. It was shown in the early 1970's that 5-alpha dihydrotestosterone (which 
cannot be transformed into testosterone or aromatized to estrogen) does not exert the 
defeminization effect exhibited by testosterone and estrogen. The fact that DHT is the common 
terminal testosterone metabolite acting upon the androgen receptor and does not exert a 
defeminizing effect supports the concept that the aromatic conversion of testosterone to estrogen 
is of importance in defeminization (45). Other studies support the aromatase hypothesis. 
First, the defeminization effects of testosterone can be blocked with estrogen antagonists (46). 
Second. there is a dramatic rise in hypothalamic 17-8 estradiol during the first hour 
post-partum in the male rat. This increase coincides with a serum and hypothalamic increase of 
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testoster011e in the male and is absent in the female. indicating that it is tinted to the presence 
. . 
or the testes and the testoster011e surge (19). Third, autoradiographic studies show extremely 
similar patterns of labelled hypothalamic cells between neonate rats injected with tritiated 
estradiot or testoster011e (31 ). Fourth, Toran-Allerand has shown that in vitro morphological 
changes produced in critical period hypothalamic cells by testosterone can be duplicated by 
estradiol (47). Fifth, evidence suggests that estradiol is, in terms or dosage administered, up to 
eight times as potent as testoster011e in inducing certain aspects or androgenizati011 (2). 
Alpha-Fetoprotein and the Protecti011 Hypothesis 
Acceptance of the aromatase hypothesis directly implies the presence or a mechanism 
~ serves to protect the genetic female's hypothalamus from being androgenized by endogenous 
estrogen from the placenta. maternal circulati011, and the fetal endocrine system. In rats and 
mice the mechanism has been elucidated. In these two species. the developing yolt sac and fetal 
liver synthesize an estrogen-binding protein (alpha-fetoprotein, AFP), which circulates at high 
levels during the latter part of gestation through critical period and gradually disappears OV!lf" 
the next few weets of life (48). AFP binds and effectively s"uesters much or the estrogen 
present in the neonate circulation, preventing its interaction with the neural substrate . 
• 
Testosterone, however, is not bound by AFP and is thus free to enter the brain. where it is 
converted by neural aromatase to 178-estradiol. Since this estrogen is now sequestered from the 
peripheral AFP protection mechanism, it may then interact with cellular estrogen receptors 
(Figure 3). 
Several studies have provided evidence that confirms the effectiveness of the AFP 
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Figure 3. Alpba-Fetoprotein Protection Hypothesis. AFP, alpba-retoprotein. 
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protection mechanism. First. the administration or AFP antibodies to neonate female rats 
mimics the effects or estradiol injections (49). Second, even though neonatal serum estradiol 
levels are high, free estradiol does not seem to be available to the tissues (50). Third; the 
synthetic estrogens Ru 2656 and diethylstilbestrol (DES) have considerably lower affinities for 
AFP than estradiol. and are more potent than estradiol in inducing differentiation of the female 
rat brain (51). 
The AFP protection hypothesis may not yet be extended to animals other than the rat 
and mouse. While AFP is present in many higher vertebrates, there seem to be different 
variants of the molecule which have different estrogen binding properties. For example, in 
humans, only 0.1 percent or AFP in circulation actually binds estrogen (52), and it does not 
appear to be present at all in the guinea pig (53). It should be noted, however. that many 
elements of the aromatase hypothesis have been demonstrated in guinea pigs and primates. As 
in the rat, treatment of the guinea pig with estradiol as well as androgen can cause an 
androgenization of the hypothalamus (54), and aromatase bas been shown to be present in the 
developing human brain (55). Thus, while in some species the AFP protection mechanism seems 
to be missing, this should not be construed as evidence indicating that the aromatase hypothesis 
does not apply, but rather that the protection mechanism is not known in these species. As was 
mentioned earlier, some investigators have proposed that progesterone may play a protective 
role in some species. 
AFP bas been found to be localized within developing nerve cells. It is interesting that 
areas that concentrate tritiated estradiol are devoid of this intracellular AFP, suggesting that 
AFP might also act as a local mediator of estrogen action (56). 
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Possible Cellular Events During Critical Period Sexual Differentiation 
There are several potential primary cellular changes which may be evoked by hormonal 
stimulation of the CNS. including steroidally-mediated cell growth and cell death, re-initiation 
of mitotic activity, changes in and/or induction of cell migration, and changes in synaptic 
connection (4.57). Of these, McEwen suggests that models involving cell growth and death are 
the most attractive and likely explanations of the mechanisms involved in sexual differentiation 
of the brain and that morphological sex differences in the brain (see Table 2) may arise from a 
combination of these two cellular events (4). Cell growth and death could be mediated in one of, 
or a combination of, several specific ways. First. perinatal hormones could selectively induce 
the death or neurons directly or, conversely, cause a stabilization or these neurons. Second, 
simple hypertrophy could be induced. with resulting changes in cell size. spread of dendritic 
branching and, ultimately, neural circuitry. Third, hypertrophy could be coupled with cell 
survival: those cells successful in establishing sufficient connection with other cells would 
survive through the developmental period, while cells that do not would be preferentially 
eliminated (58). Gorski et al. (59) have shown that the Sexually Dimorphic Nucleus of the 
Preoptic Area (SDN-POA) in the rat hypothalamus has a gross volume in the male that is 
approximately four times that of the female, and that this size difference is mediated by the 
perinatal hormonal environment. Furthermore, this volume difference is due to an actual 
difference in the size and number of neurons in the male rat's SDN-POA. Jacobson has proposed 
that hormonally-induced hypertrophy may be of importance in the development of this nucleus. 
Thus. a group of neurons in the nucleus may be hormonally induced to hypertrophy in the male 
and thus ,survive, while these same neurons in the female's SDN-POA are eliminated (57). This 
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Table 2. Androgen-Dependent Sexual Dimocphism in the CNS. Data from MacLusty and Nllftolin 
(I), except the Sexually Dimocphic Nucleus of the Preoptic Area (SDN-POA), taken from Gocsti 
et al. (59). 
Sex Difference Region Animal 
Neuronal nuclear and Preoptic area, amygdala, Rat 
nucleolar size ventromed ial hypothalamus 
Synaptic vesicles and Arcuate Rat 
terminals 
Synaptic organization Preoptic area Rat 
Dendritic branching Preoptic area: 
patterns Suprachiasmatic nucleus Hamster, rat 
Hippocampus (Ammon's Horn) Mouse 
Gross nuclear volume Preoptic area: 
SDN-POA Rat 
Lumbar spinal cord 
Nucleus robustus archistriatalis, Zebra finch 
nucleus hyperstriatum ventrale 
pars caudal is 
is a particularly interesting model, considering that a rat is born with many more neurons than 
it will possess as an adult, and that the loss of neurons is a normal part of post-partum brain 
development (2). 
The hypothesis that steroidally-mediated hypertrophy may act as a mechanism of 
sexual dlfferentiatlon or the brain ls strongly supported by the In vitro studies performed on 
hypothalamic explants from neonate mice performed by Toran-Allerand (47). These studies 
revealed that treatment of critical period tissue with either testosterone or estradiol resulted in 
. - ' ..... -·, \._., ... 
. ... •,--•• ', __ 
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a dramatic oeurite outgrowth .w.ith extensive arborizatioo of the new processes in a 
dose-dependent fashion. This hormonally-stimulated growth involves only small groups of 
neurons: not all cells io a given nucleus appear to be steroid-sensitive. Thus. these in vitro 
effects appear to be highly specific morphologically, with the most sensitive neurons located in 
the estrogen-receptor rich anterior preoptic and iofuodibular-premammillary regions. 
Female Sex Behavior 
Introduction of a normal, sexually receptive female into the home cage of a oor111al, 
sexually vigorous male rat results in the following behavioral events. usually occurring 
sequentially. The male investigates the female, particularly her anal-genital region. The 
receptive female displays several solicitory behaviors, the more obvious of which are rapid 
quivering or the ears and abrupt darting across the cage, usually with the male in pursuit. At 
intervals the male mounts the female. palpates her flanks with his forelegs, and exhibits pelvic 
thrusting as be attempts intromission. For the male to achieve intromission the female exhibits 
a characteristic behavioral response called lordosis. During lordosis the female deflects her 
tail laterally and arches her back so that both her bead and perineum are elevated. Arter a 
brief mount the male dismounts. the behavior or which depends on whether or not be bas 
ejaculated (which usually occurs only after a series or intromissions, and is followed by a brief 
refractory period). High levels of sexual receptivity can be induced in intact or ovariectomized 
females by estrogen-progesterone priming, and some female sex behavior may be elicited from 
the castrated male by the same procedure (60). lo many studies quantification or female sex 
behavior (and thus, as in this study, quantification or degree or defeminization) is accomplished 
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by the tordosis quotient. which is the number of tordosis responses divided by the number of 
mounts, multiplied by 100 (60). 
Possible Androgen Receptor Involvement in Defeminization/Masculinization 
Despite the previously mentioned massive 111:cumulation of evidence indicating that 
defeminization is dependent upon the estrogen receptor. some recent research suggests that the 
androgen receptor lllllY also play a role in sexual differentiation of the CNS. Gladue and Clemens 
(10) report that long-term (days 10-22 post-conception) prenatal exposure to the non-steroidal 
anti-androgen Ilutamide can attenuate the defeminization process. Olson (61) has shown that 
female sex beba.vior can be attenuated by postnatal treatment with the synthetic anti-androgen 
R-188 t. which is believed to bind to androgen receptor and is not metabolized to other 
androgens or estrogens. 
Additionally, Meany et al. (62) have shown. with studies utilizing rtutamide and 
androgen-insensitive testicular feminization mutation (Tfm) males, that the sexual 
differentiation of social play (a masculinization event) is very probably mediated by the 
androgen receptor system. 
Flutamide 
In the initial biological profile, Neri states that rtutamide is a highly potent 
anti-androgen with no androgenic, estrogenic, anti-estrogenic, corticoid, progestational, 
anti-progestational. or anti-gonadotrophic properties (63). However. it has been shown that 
prenatal exposure to flutamide can attenuate defeminization in the rat (I 0). On the basis of 
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resean:h by Gladue et al. comparing the effects of rtutamide and an anti-aromatase on 
hormonally-mediated behavior (64), McEwen has suggested that the effects of rtutamide on 
defeminization are due to anti-aromatase activity (4). As this drug is becoming more comm:only 
used in sexual differentiation research, clarification of this point is needed to al'oid data 
misinterpretation. 
Clomiphene 
The effects of clomiphene, historically described as an anti-estrogen (65). are 
enormously complex and poorly understood. In humans, low doses of clomiphene are commonly 
used to induce ovulation by antagonistic blockade of estrogen-mediated negative feedback 
mechansims. HO'l'ever. at high doses clomiphene exerts an estrogenic effect upon this systeJ!I. 
and a review of the literature prUYides evidence that clomiphene may act as an estrogen agonist, 
an antagonist. or both depending on the species of animal. the tissue, and the dosages 
administered (66). 
· A recent study by Bowman et al. (67) on the effects of clomiphene upon 
estrogen-mediated events in the uterus, pituitary and brain of the adult female Sprague-Dawley 
rat indicated the following. Pure agonism was demonstrated for food intake regulation and body 
weight, while pure antagonism was demonstrated for female sexual behaviour, prolactin 
secretion and possibly the production of uterine luminal fluid. Partial agonism was observed 
upon FSH and LH secretion and uterine weight. Also, an attempt was made to correlate these 
findings with 'cytoplasmic' receptor data previously obtained by Kurt and Morris (68). Even 
though there is a tremendous amount of evidence that clomiphene exerts its effects through the 
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estrogen receptor system by high affinity binding to the receptor with resulting depletion of the 
'cytoplasmic' form of receptor (68,69,70,71,72,73,74), no consistent relationship between the 
receptor distributions obsen-ed by Kurt and Morris and the final effects obsen-ed by_ Bowman et 
al. were found. 
Clari: and Guthrie (66), in studies performed upon rat uterus, suggest that clomiphene 
exerted both agonistic and antagonistic effects over the same doses. This conclusion was arrived 
at by noting that clomiphene alone had an estrogenic effect upon uterine weight. but. at the same 
dosage, attenuated the effects of additionally injected estrogen benzoate. On the basis of this 
and other data. Clarke and Guthrie state that generali2ed statements regarding the estrogenicity 
or anti-estrogenicity of clomiphene are invalid. 
Research by Adashi et al. (69) indicates that. while nuclear processing in the rat uterus 
is routinely observed bet.ween one and five hours after a single injection of estradiol, a I 0.0 mg 
dose of clomiphene results in persistent. dose related accumulation of receptor in the nucleus 
for at least 14 days. It was determined that this phenomenon was the result of prolonged 
retention of 'nuclear' receptor rather than a slow release from the injection· site. It was also 
determined that clomiphene induces the synthesis of estrogen receptor in uterine tissue. 
Similar receptor results were found in the pituitary, but only very short-lived alterations in 
receptor distribution could be discerned in the hypothalamus. While experiments using 0.5 
and 5.0 mg/kg dosages of clomiphene in adult rats indicated that such CNS mediated parameters 
as food intake and body weight were significantly affected ( 67), brain cytoplasmic receptor 
studies indicated that clomiphene does not enter the brain of the adult rat at these same dosages 
(68). 
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Only one published study. in the rat examines the behavioral effects of clomiphene 
following neonatal administration (75). No clomiphene treated animals in this study were BVer 
obs8"ed to lordose over multiple trials, while controls exhibited a mean lordosis quotient of 
66.1. Poor design, howBVer, weakens these findings. First, no animals were gonadectomized, a 
procedure that allows for some degree of standardization of the hormonal milieu and aids in 
relating data ·10 changes imposed upon the brain rather than changes imposed upon the gonads. 
Second. this study did not make use of estrogen-progesterone priming, which is normally used 
in sex differentiation studies. Third, the article states that "The most probable way in which 
the drug acts in this study is for it to have gone to estrogen receptors and there either modified 
the receptor shape or permanently bonded to it,· without any mention of the aromatase theory or 
the probable role of the estrogen receptor in sexual differentiation of the CNS. 
Research Objectives 
In this study, neonate rats were subjected to a variety of injections in order to further 
elucidate the effects of progesterone. clomiphene and flutamide. and to clarify the role of the 
androgen receptor in differentiation of the CNS. Testing of the following hypotheses was 
accomplished by examination of the adult behavior and hypothalamic morphology of these 
animals. 
Progesterone. While alpha-fetoprotein is certainly the primary mechanism responsible 
for protecting the hypothalamus in the rat, it does not seem to be in other animals (52,53). 
Progesterone has been suggested as a possible mechanism in these other species 0.2.4.9). 
Additionally, research performed by Kincl and Maqueo suggests that progesterone plays a 
protective role in the rat (22). 
It was hypothesized that progesterone could exert an attenuatory· elfect upon 
defeminization in the rat. 
Clomiphene. Only one study in the rat on the behavioral effects of neonatal treatment 
with clomiphene has been published (75). and the results of this study are weakened by poor 
experimental design. 
It was hypothesized that clomiphene acted as a powerful estrogen agonist upon neonatal 
hypothalamic tissue. 
Flutamide. There is evidence from which it has been inferred that flutamide has 
anti-aromatase activity (I 0,64). As this drug is coming into more common use in the 
investigation of the role of the androgen receptor in differentiation of the CNS. it is important 
that this possibility be investigated. 
It was hypothesized that flutamide bas anti-aromatase activity. 
The Androgen Receptor. There is a growing body of evidence that the androgen receptor 
system may play a role in differentiation of the CNS (I 0.61.62). 
It was hypothesized that the androgen receptor could affect the defeminization and/or 
masculinization of the hypothalamus. 
. MATERIALS AND METHODS 
Animal Treatment 
Neonate rats or the Sprague-Dawley strain were obtained from the Lappin Ha.II colony of 
Morehead State University. On the day of birth. animals were sexed a.nd assigned to one of 14 
experimental groups or a control group. Animals were then subjected to subcutaneous 
injections according to the schedule shown in Table 3. Testosterone propionate, estrogen 
benzoate, progesterone and clomiphene citrate were obtained from Sigma Chemical Company. 
Fluta.mide (4'-oitro-3'-triflouromethylisobutyra.nilide) was graciously provided by the 
Scbering Corporation. Animals were then bDUSed at 22° C under a 1-1:10 day-night cycle (on al 
0400 hours, off at 1800 hours) and supplied with water and Purina Laboratory Chow (Ralston 
Purina Co., St. Louis, Mo.) ad libitum. 
At 60 :I: 5 days all animals were anesthetized with ether or peotabarbital (The Butler 
Co., Columbus, Ohio) and subjected to bilateral gonadectomy. Surgery was performed on females 
using a dorsal approach, a.nd a medial. trans-scrotal approach was used on males. Blood vessels 
and muscle layers were tied with 4-0 chromic. Skin closure on females was done with wound 
clips: males were closed with 4-0 silk. using an interrupted stitch. Immediately following 
surgery, all animals were given a single IP injection of penicillin (3.0 mg in 0.5 ml sterile 
saline). The animals were then allowed a two-week recovery period before behavioral testing. 
Behavioral Testing 
All animals were given a I 0.0 µg IM injection of estrogen benzoa.te in 0.1 ml peanut oil 
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Table 3. Schedule of Treatments Administer-ed to Animals During Critical Per-iod. 
Group Number N. 
l male 3 
female 3 
2 male 4 
female 4 
3 male 5 
female 5 
male 5 
female s 
5 female 5 
6 female 5 
7 male 6 
female 5 
8 male 5 
female s 
male 4 
female 7 
10 male 8 
female 3 
II male s 
female 6 
Treatment 
1.0 mg testostet"ODe 
propionate 
0.25 mg estrogen 
benzoate 
0.25 mg clomiphene 
1.0 mg progest=e 
0.1 ml propylene glycol 
followed by 1.0 mg 
testoster-one propionate 
0.5 mg flutamide followed 
by 1.0 mg testosterone 
propionate 
0.5 mg flutamide 
0.5 mg flutamide 
1.0 mg progesterone 
1.0 mg progestet"ODe 
0.5 mg flutamide followed 
by 0.25 mg estrogen 
benzoate 
Day(s) Post-Partum 
Injections @yen 
1&6 
1&6 
I, 3.5. 7.&9 
I 
6 
1&6 
6 
1&6 
22 
. 
"-~:-,.:-::"/, . 
Table I. (Continued From Previous Page). 
Group Number · Sex 
12 
13 
14 
15 
male 
female 
male 
female 
male 
male 
Note. Total N • 125. 
!'! 
3 
6 
4 
Treatment 
0.1 ml peanut oil only 
2.0 mg flutamide followed 
0 (a) by 0.25 mg estrogen 
ben203le 
II 
3 
0.25 mg clomiphene 
0.25 mg clomiphene & 
o.:; ms flutamide 
,':"::-.,:; - ·_.;_.-,., -· 
-- ' ,. -
Day(sj Post-Partum 
Injections Given 
I 
1&6 
I & 6 
1&6 
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Note. Flutamide was administered in 0.1 ml of propylene glycol. Clomiphene citrate was 
administered in 0.1 ml sterile saline. All other treatments were administered in 0.1 ml peanut 
oil. 
(a) While it had been planned to include females in this group, it proved impossible to do so 
because of their extremely high death rate. 
at -72, -48 and -24 hours. Four hours prior to testing, a 500.0 µg IM injection of progesterone 
was administered. Actual testing commenced at 1830 hours, 30 minutes after the beginning of 
the animals nocturnal cycle, and normally continued (three animals at a time) until 0300 hours, 
60 minutes prior to the end or the nocturnal cycle. Testing took place in clear plexiglass cages 
under dim red lighting, which has been shown to provide minimum interference with the 
animals" normal nocturnal behavior (60). 
Lordosis behavior (which is indicative of the degree of defeminization) was quantified 
for each animal using the lordosis quotient: LQ • frequency or lordosis In response to mounts 
• ·. -_",.;~t-/.,-:£:_p··:~r.ti!-::_~ 2 -4 
4. ' ' ' ~ 
+ number of mounts x I 00. Animals were placed in the home cage of a sexually vigorous male. 
Testing was begun after a IO minute adaptation period, or upon the first mount that stimulated 
lordosis. whichever came first. Testing continued for ten mounts or for 45 minutes. If no 
mounts and no signs or sexual receptiYity occurred within the first 20 minutes, testing was 
discontinued and a lordosis quotient of 0 was recorded. 
Evaluation or the Sexually Dimorphic Nucleus of the Preoptic Area 
Within 24 hours of the completion of behavioral testing and while under light ether 
anesthesia. animals were first intracardially perfused with 0.9% saline and then with I 0.0% 
formalin. The animals were then decapitated and the beads stored in I 0.0% formalin for 24 
hours. Utilizing a ventral aproacb. the brains were then removed and placed in numbered 
culture tubes containing I 0% formalin for at least two weeks. 
Brains were embedded in paraffin. sectioned at 40.0 I.Im, and nissl stained with cresyl 
violet acetate (Sigma Chemical Company) according to the method of Powers and Clark (76). Two 
sections were selected on the basis of the surrou11ding anatomy as being the aproximate center 
of the SDN-POA (see Figure 4). These sections were projected onto a sheet of white paper, and 
the SDN-POA. along with any pertinent surrounding structures. were traced. A planimeter that 
bad been callibrated with a similarly projected and traced 1.0 mm grid was used to obtain an 
average square mm measurement of the SDN-POA from those tracings. 
Statistical Analysis 
All data were first screened with SAS means and univariate procedures. 2-way ANOV A 
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and Duncan's Multiple Range Test were then performed on all data using SAS General Linear 
Models (OLM) procedures. Results of p i_.05 were considered to be significant . 
. iWj:.{JJ. 
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Figure 4. Illustration of Coronal Section Through the Approximate Center of the SDN-POA. AC, 
anterior commisure: QC, optic chiasma. V-III. third ventricle. Adapted from Gorski 
et al. (59). 
RESULTS 
Analysis of Defemioization 
The LQ data were initially screened with SAS means and univariate procedures (see 
Table 4 and Figure 5 for partial output). Since this screening revealed no violations of the 
mathematical requirements for analysis of variance, a two-way ANOVA was performed on the LQ 
data. This test indicated that the effect of treatment was significant. E • 5.9. JL• .0001. The sex 
of the animal also had a significant effect, E • 177.222, I!.• 0.0001. However, the treatment 
group by sex interaction was also significant. F • 11.75. I!. • 0.0001. thus precluding 
interpretation of these effects (see Table 6). The interaction was analyzed by means of a 
Duncan's post hoc test, the full results of which are shown in Table 8. A simplified summary of 
those results is given in Ta.hie 9. 
Progesterone. The group 4. female results indicate that 1.0 mg doses of progesterone 
given on days 1,3.5,7 and 9 post-partum can have a significant defeminization effect (Table 8, 
summary Table 9). However. since neither group 9 or 10 (1.0 mg of progesterone on day I or 6, 
respectively) achieved statistical significance (Table 8), group 4 results may be a 
pharmacological effect. 
Clomiphene. The group 3, female results indicate that a single, 0.25 mg injection of 
clomiphene given on day I post-partum can have a significant defeminization effect (Table 8, 
summary Table 9). Considering the role of the estrogen receptor in differentiation of the CNS, 
this data indicates that clomiphene acted as an extremely potent estrogen agonist. 
Flutamide and the Androgen Receptor System. In order to determine if flutamide 
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exerted anti-aromatase effects, one group or females were treated with 0.5 mg flutamide followed 
by 1.0 mg testosterone propionate (group 6). and another group was treated with testosterone 
propionate only (group 51. Group 6 was found to be significantly less defeminized than group 5. 
indicating that rtutamide significantly attenuated testosterone propionate-induced 
defeminization (Table 8, summary Table 91. 
Additionally, comparison of group 11 and group 2 animals (respectively, 0.5 mg 
flutamide followed by 0.25 mg estrogen benzoate on days I & 6 post partum. and 0.25 mg 
estrogen benzoate only on days I & 6 post-partum) revealed no significant difference between 
males or females (Table 8). This suggests that flutamide does not affect estrogen 
benzoate-induced defeminization. Group 13, male (which was treated with four times the dose of 
flutamide used in group 11. followed by 0.25 mg estrogen benzoate) was also not significantly 
different from group 2, male (Table 8), again suggesting that rtutamide is not capable of 
attenuating defeminization when a supply of estrogen is available to the animal for this process. 
Group 7, male (0.5 mg rtutamide on day 6 post-partum) evidenced no significant 
attenuation of defeminization in comparison to control males (Table 8), suggesting that this 
effect of flutamide may be limited to early critical period. Group 8, male (0.5 mg flutamide on 
days I & 6 post-partum). while not significantly more feminine in their behavior than controls, 
did show a higher (22 as compared to 15.8) LQ mean (Table 8). 
No significant differences were round between testosterone propionate- and estrogen 
benzoate-defeminized animals (Table 8, groups I and 2). 
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Evaluation of the SDN-POA 
. . 
The SDN-POA data were initially screened with SAS means and univariate procedures 
(see Table 5 and Figure 6 for partial output). Although this screening revealed several 
violations of the mathematical requirements for analysis of variance, a two-way ANOVA was 
nonetheless performed on the SDN-POA data. This test indicated that the effect of treatment 
groups was not significant, E • 1.25, IL" 0.33. The effect of sex was also not significant, f....• 
3.88, 11. - 0.065. (see Table 7). However. it should be noted that the total N for this data was only 
36, which strongly increases the probability of type II error. 
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Figure 6. Bar graph of Group SDN-POA Means. 
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Table 4. SAS Statistics Output on the Lordosis Quotient Data. SEM. standard error of the mean: 
CV, coemcient or variation. The CV is the ratio between the standard deviation of the 
sample and the mean of the sample expressed as a percent. ' 
Group Sex N. Mean Std. Deviation SEM CV 
F 3 0 0 0 
M 3 0 0 0 
2 F 4 0 0 0 
2 M 4 0 0 0 
3 'F ,5 0 0 0 
3 M 5 0 0 0 
4 F 5 41.22 6.03 2.70 14.62 
4 M 5 5.32 8.69 3.89 163.34 
5 F 5 JO 17.32 7.75 173.21 
6 F 5 33.32 21.71 9.71 65.11 
7 F 5 68 8.37 3.74 12.30. 
7 M 6 7.92 10.05 4.10 126.97 
8 F 5 70 24.49 10.95 34.99 
8 M 5 22 13.04 5.83 59.27 
9 F 7 55.71 12.72 4.81 22.83 
9 M 4 6.25 7.22 3.61 115.41 
JO F 3 60 ID 5.77 16.67 
10 M 8 5.54 8.10 2.86 1'16.26 
II F ·6 11.10 11.87 4.85 106.92 
II ·M 5 0 0 0 
12 F 4 67.50 17.08 8.54 25.30 
12 M 3 15.83 16.71 9.65 105.54 
13 M 4 5 10 5 200 
14 M 10 0 0 0 
15 M 3 2.20 3.81 2.20 173.21 
.. · 32 
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Table 5. SAS Statistics Output 011 the SDN-POA Data. SEM. standard errDI" or the mean: CV. 
Group 
I 
2 
2 
3 
3 
4 
4 
5 
6 
7 
7 
8 
8 
9 
9 
10 
10 
11 
11 
12 
12 
13 
14 
15 
coefficient or variation. · The CV is the ratio between the standard deviati011 or the 
sample and the mean or the sample expressed as a percent. SDN in square mm. 
Sex N. Mean Std. Deviation SEM CV 
F 0.036 
M 0.032 
F I 0.032 
M 2 0.036 0.0057 0.0040 15.713 
F 2 0.018 0.0078 0.0055 44.447 
M 0.032 
F I 0.012 
M 2 0.009 0.0042 0.0030 47.140 
F 0 
F 2 0.036 0.0057 0.0040 15.713 
F 0.012 
M 4 0.030 0.0185 0.0093 61.704 
F 0 
M 0 
F 2 0.011 0.0014 0.0010 12.856 
M I 0.024 
F I 0.016 
M 3 0.043 0.0197 0.0.111 45.750 
F 2 0.009 0.0042 0.0030 47.140 
M 0 
F 2 0.011 0.0014 0.0010 12.856 
M 0.032 
M I 0.024 
M 6 0.024 0.0142 0.0058 58.157 
M 0.032 
Table 6. ANOVA Summary: Dependent Variable• LQ. Total N • 122. 
Source DF Tv11e IV SS !: Value 
Group 14 9918.91 5.90 
Sex I 21285.60 177.22 
Group by Sex 9 12703.64 11.75 
Table 7. ANOVA Summary: Dependent Variable• SDN-POA. Total N • 38 
Group 
Sex 
Group by Sex 
DF 
12 
I 
7 
JYl!e IV SS 
0.0026 
0.0007 
0.0006 
F Value 
l_.25 
3.88 
0.47 
P.!u.E 
0.0001 
0.000 I 
0.0001 
PR >F 
0.3305 
0.0653 
0.!1416 
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Table 8. Full Results of SAS Duncan's Multiple Range Test for LQ. Alpha• 0.05. DP• 97. MSE • 
120.11. This chart is interpreted by comparing the letters listed for any two means. 
If the two means being compared have one or more letters in common, they are not 
1ignificantly different. 
Grou11ing Mean li Grou11 Sex 
A 70 5 8 F 
A 68 5 7 F 
A 67.50 4 12.(CONTROL) F 
A 60 3 10 F 
B A 55.71 7 9 F 
B C 41.22 5 4 F 
D C 33.32 5 6 F 
D E 22 5 8 M 
F E 15.83 3 12.( CONTROL) M 
F E I 1.10 6 II F 
F E 10 5 5 F 
F E 7.92 6 7 M 
F E 6.25 4 9 M 
F E 5.54 8 10 M 
F E 5.32 5 4 M 
F E 5 4 13 M 
F 2.20 3 15 M 
F 0 3 I F 
F 0 4 2 F 
F 0 5 3 M 
F 0 5 3 F 
F 0 10 14 M 
F 0 3 I M 
F 0 5 II M 
F 0 4 2 M 
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Table 9. SAS Duncan's Multiple Range Test for LQ Summary. The groups listed below consist of 
females only; no male groups achieved statistical significance. Groups with the symbol 
' are significantly defeminized in comparison to controls. Groups with the symbol • 
are significantly different from each other. C, clomiphene: EB, estrogen benzoate: F, 
flutamide: P. progesterone: PG, propylene glycol: TP, testosterone propionate. 
Grou11 Number N. Treatment !l!!X!sl Post-Partum 
Injections Given 
' I 3 I.0mgTP I & 6 
'2 4 0.25 mg EB I & 6 
'3 5 0.25mg C I 
'4 5 1.0 mgP 1,3.5.7 & 9 
"'5 5 0.1 ml PG followed I 
by I.0mgTP 
"'6 5 0.5 mg F followed I 
, ' 
by 1.0 mg TP 
I 11 6 0.5 mg F followed I & 6 
by 0.25 mg EB 
Note. In some cases, groups which did not achieve statistical significance were of importance in 
the interpretation or the results of this study. A discussion of these cases Is Included in the 
text of this chapter. 
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DISCUSSION 
Progesterone 
The hypothesis that progesterone could attenuate dereminization in the rat was rejected. 
This conclusion contradicts the wort or Kincl and Maqueo (22). whose results (obtained from 
neonatal treatment or female rats) suggest that progesterone can protect the neonatal rat 
hypothalamus from the e£fects or testosterone. Differences in the results obtained by Kincl and 
Maqueo and those obtained in this study may be explained by the considerable differences in 
the experimental protocol used to examine the errects of progesterone. Kincl and Maqueo 
administered much smaller doses or t115tosterone propionate (50.0 and I 00.0 p.g) and much 
greater doses of progesterone (3000.0 p.g) than those used in this study. Additionally. the rats 
were not subjected to these treatments until day 5 post-partum, and the effects were interpreted 
, 
purely on the ~asis of whether or not the animals,' ovaries appeared to be luteal on day 45 
post-partum. 
Although this study does not provide any evidence that progesterone can protect the rat 
hypothalamus against the effects of testosterone, it does not eliminate the possibility that 
progesterone could be of importance in other animals. or could have effects in the rat different 
from those found in this study at different dosages. Progesterone is transformed to 
5-alpba-dihydroprogesterone by 5-alpba-reductase. the enzyme which transforms testosterone 
to DHT. This fact, combined with possible sex differences in serum progesterone in some 
species. bas led several researchers to suggest that progesterone may play a role in 
differentiation of the CNS (1,2.4.~). The presence of ovaries bas been shown to inhibit the 
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defeminizing effects of testosterone in the rat (21 ). A future study should attempt to determine 
' ' <·_:.::;',: " 
if this effect is due to progesterone by providing a careful examination of the effects in the rat 
of progesterone in physiological. rather than pharmacological. quantities. Additionally. ,an 
examination of the effects of progesterone in the guinea pig would be particularly commendable 
as a future study. considering this animal's apparent tact of alpba-fetoprotein (53). 
Clomiphene 
The estrogenic/anti-estrogenic effects of clomiphene are enormously complex and 
poorly understood. There is evidence that ctomiphene may act as an estrogen agonist. an 
antagonist. or both depending on the species of animal. the tissue, and dosages administered 
(66.67). It is believed that clomiphene exerts its effects through the estrogen receptor system 
by long-term, high affinity binding to the receptor (69), with resulting depletion of the 
'cytosolic' form of the receptor (68.69.70.71.72.73.74). 
Animals treated with clomiphene ii! this study were highly defeminized, as evidenced 
by their failure to lordose (Table 8, summary Table 9). This suggests that, at a dosage of 0.25 
mg, this drug acted as an agonist upon neonatal rat bypothalamic tissue. It should, however, be 
noted that Clarl::e and Guthrie (66) suggest that clomiphene may act as both an agonist and an 
antagonist over the same doses in uterine tissue. They found that, while clomiphene alone had 
an estrogenic effect upon uterine weight. the same dosage would attenuate the agonism of 
injected estrogen. A similar situation could exist in the neonatal rat hypothalamus. 
Some qualitative data of interest was obtained on clomiphene-trealed animals. two of 
five males and three of five females in group 3 actively attacked the non-experimental male. A 
.. ;,-
similar behavioral obsenration was made in clomiphene-treated males of group 14, five of ten 
', 
. ,•: : ,·•' '. 
mates actively attacting the non-experimental mate. This level of aggression was not noted in 
testosterone or estrogen treated animals, and was surprising considering that these animals did 
not have any gonadally-produced testosterone available to them at the time of testing. White it 
is possible this was a behavioral result of the neonatal administratien of clomiphene, another 
explanation may be derived. from the fact that ctomiphene seemed to cause considerable genital 
malformation and resulting infection of the genital region in these animals, and thus the 
aggressive behavior obsenred may have been the result of pain. 
Despite the considerable differences in experimental protocol. these results are in 
basic agreement with those obtained by Fitzpatrict et al., who also found that a complete 
repressien of lordosis behavior followed the neenatal administration of clomiphene (75). 
Flutamide and the Androgen Receptor System 
This study shows that neonatal administration of ftutamide can significantly attenuate 
testosterone-induced defeminizatien, and that this effect seems to be more pronounced during 
the first few days post-partum (Table 8, summary Table 9). Furthermore, ftutamide does not 
seem to be capable of affecting estrogen-induced defeminizatien (Table 8). On the basis of 
research by Gladue et al. comparing the effects of ftutamide and an anti-aromatase on 
hormonally-mediated behavior (64), McEwen has suggested that the effects of ftutamide on 
defeminizatien are due to anti-aromatase activity (4). The results obtained in this study 
indicate that ftutamide does indeed affect defeminization by exerting an inhibitory influence 
upon aromatase activity. However, en the basis or recent research by Roselli and Resto (77), I 
' . 
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suggest that this is not a direct i_nhibition of the enzyme. but rather a consequence of blocking 
the androgen receptor. 
Roselli and Resto (77) have provided extremely convincing evidence that aromatase 
activity in the hypothalamic-preoptic area is controlled by testosterone through a receptor 
mechanism. Aromatase activity in this area of the adult. male rat brain fell by 60 percent 
following castration, and Silastic implantation of testosterone or DHT reversed the effect of 
castration. Neither progesterone or estradiol implantation affected the post-castration levels of 
aromatase activity. Furthermore, flutamide was found to block the testosterone or DHT induced 
reversal of post-castration aromatase levels. while having no effect when given alone to castrated 
rats. Research following the methodology of Roselli and Resto needs to be performed on neonatal 
tissue to determine if this mechanism of androgen receptor control of aromatase activity exists 
during critical period. If this is indeed the case, it would suggest an important' role for the 
androgen receptor system in the regulation of defeminization. possibly acting as a local 
modulator of aromatase activity and thus defeminization. A model such as this could provide an 
explanation for the anti-defeminization effect of flutamide observed in this study. and in the 
research of Gladue and Clemens (ID). This model could also explain the results obtained by 
Olson. who has shown that the anti-androgen R-1881 can attenuate defeminization (61). 
No other evidence of androgen receptor influence upon defeminization was found in the 
lordosis studies. though it should be remembered that there is strong evidence of androgen 
receptor involvement in the development of masculine behavior. Meany et al. (62) have shown 
that the sexual differentiation of social play (a masculinization event) is dependent on the 
androgen receptor. It is unfortunate that the amount of data on the SDN-POA was so limited that 
40 
an a priori prediction of non-significance could be made. However. it is worth noting (bearing 
in mind that statistical significance was not achieved) that the SDN-POA seems to be 
masculinized by both testosterone and estradiol. indicating that this particular masculinization 
event involves aromatase. 
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